Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2/B Chimera After Intranasal Delivery

Toxins - Switzerland
doi 10.3390/toxins6041397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Mucosal Immunization With a Staphylococcus Aureus IsdA-Cholera Toxin A2/B Chimera Induces Antigen-Specific Th2-Type Responses in Mice

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2011English

Proinflammatory Responses in the Murine Brain After Intranasal Delivery of Cholera Toxin: Implications for the Use of AB Toxins as Adjuvants in Intranasal Vaccines

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
2005English

Efficient Cholera Toxin B Subunit‐Based Nanoparticles With MRI Capability for Drug Delivery to the Brain Following Intranasal Administration

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2019English

West Nile Virus

JAMA - Journal of the American Medical Association
Medicine
2012English

Phospholipase A2 Activity During the Replication Cycle of the Flavivirus West Nile Virus

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

West Nile Virus

CMAJ
Medicine
2005English

West Nile Virus Infection

CMAJ
Medicine
2013English

West Nile Virus Infection

Progress in Transplantation
Transplantation
2003English

West Nile Virus: Round Five

CMAJ
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy